We sought to test the hypothesis that the expression of CSF-1R protein on carcinoma cells will identify tumors with aggressive features and provide prognostic information in ER+ breast cancers, identifying a subgroup of patients associated with poor clinical outcome. This evidence concerns the gene CSF1R and breast carcinoma.